Remove 2030 Remove Biotech Remove Biotechnology
article thumbnail

Pharma & Biotech in 2025: The Top 6 Growth Opportunities Shaping the Future

Frost & Sullivan

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. Download our full analysis on the top 6 growth opportunities in pharma and biotech. By 2030, the RLT market is projected to reach $13.07

Biotech 52
article thumbnail

The Global Growth of Cardiac Biomarkers Diagnostics: Innovations, Growth Drivers, and Opportunities (2024-2029)

Frost & Sullivan

million by 2030, emphasizing the need for early and accurate diagnostics. Elabscience Biotechnology, Inc., Download our full analysis on Cardiac Biomarkers Diagnostics. Click here to download According to the World Health Organization (WHO), CVD-related deaths are projected to reach 23.3 Quanterix, Response Biomedical Corp.,